Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Imaging, Three-Dimensional | 5 | 2016 | 84 | 1.810 |
Why?
|
| Mammaplasty | 4 | 2022 | 8 | 1.250 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2013 | 173 | 0.910 |
Why?
|
| Zebrafish | 4 | 2016 | 128 | 0.880 |
Why?
|
| Breast | 4 | 2022 | 135 | 0.860 |
Why?
|
| Toxicity Tests | 2 | 2013 | 43 | 0.810 |
Why?
|
| Algorithms | 4 | 2013 | 465 | 0.780 |
Why?
|
| Breast Neoplasms | 6 | 2023 | 1502 | 0.740 |
Why?
|
| Silicon | 1 | 2020 | 17 | 0.720 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 62 | 0.690 |
Why?
|
| Mass Screening | 1 | 2022 | 462 | 0.640 |
Why?
|
| Automation | 2 | 2013 | 22 | 0.540 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2013 | 53 | 0.520 |
Why?
|
| Cell Nucleus | 2 | 2014 | 366 | 0.510 |
Why?
|
| Embryo, Nonmammalian | 3 | 2016 | 59 | 0.490 |
Why?
|
| Environmental Pollutants | 2 | 2016 | 179 | 0.490 |
Why?
|
| Blood Vessels | 1 | 2011 | 34 | 0.380 |
Why?
|
| Mastectomy | 3 | 2021 | 15 | 0.370 |
Why?
|
| Biological Assay | 1 | 2011 | 59 | 0.370 |
Why?
|
| Computer Communication Networks | 1 | 2010 | 13 | 0.360 |
Why?
|
| Medical Informatics | 1 | 2010 | 21 | 0.350 |
Why?
|
| User-Computer Interface | 1 | 2010 | 62 | 0.350 |
Why?
|
| Arsenic | 1 | 2011 | 144 | 0.330 |
Why?
|
| Software | 1 | 2010 | 217 | 0.310 |
Why?
|
| Humans | 20 | 2023 | 37093 | 0.300 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 145 | 0.280 |
Why?
|
| Telemedicine | 1 | 2010 | 182 | 0.270 |
Why?
|
| Autophagy | 2 | 2016 | 116 | 0.230 |
Why?
|
| Glioblastoma | 2 | 2014 | 55 | 0.220 |
Why?
|
| Autoanalysis | 1 | 2002 | 2 | 0.220 |
Why?
|
| Image Cytometry | 1 | 2002 | 7 | 0.220 |
Why?
|
| Prenatal Diagnosis | 1 | 2002 | 12 | 0.220 |
Why?
|
| Fetus | 1 | 2002 | 105 | 0.210 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 146 | 0.210 |
Why?
|
| Transplantation, Autologous | 1 | 2021 | 8 | 0.200 |
Why?
|
| Models, Theoretical | 2 | 2013 | 217 | 0.180 |
Why?
|
| Boron Compounds | 1 | 2020 | 16 | 0.180 |
Why?
|
| Nanocomposites | 1 | 2020 | 19 | 0.180 |
Why?
|
| Titanium | 1 | 2020 | 36 | 0.180 |
Why?
|
| Adipose Tissue | 1 | 2021 | 177 | 0.180 |
Why?
|
| Cell Adhesion | 1 | 2020 | 212 | 0.170 |
Why?
|
| Fruit | 1 | 2020 | 173 | 0.160 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 64 | 0.150 |
Why?
|
| Cosmetic Techniques | 1 | 2016 | 4 | 0.150 |
Why?
|
| Quality of Life | 2 | 2022 | 481 | 0.150 |
Why?
|
| Body Image | 1 | 2017 | 84 | 0.140 |
Why?
|
| Photogrammetry | 1 | 2016 | 1 | 0.140 |
Why?
|
| Normal Distribution | 1 | 2016 | 14 | 0.140 |
Why?
|
| Animals, Genetically Modified | 2 | 2016 | 99 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2016 | 33 | 0.140 |
Why?
|
| Androgens | 2 | 2016 | 89 | 0.140 |
Why?
|
| Lysosomes | 1 | 2016 | 91 | 0.140 |
Why?
|
| Embryonic Development | 1 | 2016 | 76 | 0.140 |
Why?
|
| Anthropometry | 1 | 2016 | 97 | 0.140 |
Why?
|
| Female | 9 | 2023 | 20969 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 126 | 0.130 |
Why?
|
| Prostatic Neoplasms | 2 | 2016 | 935 | 0.130 |
Why?
|
| Middle Aged | 5 | 2017 | 10129 | 0.130 |
Why?
|
| Posture | 1 | 2015 | 58 | 0.130 |
Why?
|
| Sodium Compounds | 1 | 2014 | 11 | 0.120 |
Why?
|
| Disease Progression | 1 | 2016 | 601 | 0.120 |
Why?
|
| Diploidy | 1 | 2013 | 6 | 0.120 |
Why?
|
| Aneuploidy | 1 | 2013 | 23 | 0.120 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 578 | 0.120 |
Why?
|
| Cell Line | 2 | 2016 | 1354 | 0.120 |
Why?
|
| Arsenites | 1 | 2014 | 51 | 0.120 |
Why?
|
| Adoptive Transfer | 1 | 2013 | 48 | 0.110 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 89 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 73 | 0.110 |
Why?
|
| Adult | 5 | 2017 | 11712 | 0.110 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 59 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2016 | 308 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2013 | 55 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 59 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 111 | 0.110 |
Why?
|
| Models, Animal | 1 | 2013 | 134 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 286 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 935 | 0.100 |
Why?
|
| Water Pollutants, Chemical | 1 | 2014 | 164 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 513 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 807 | 0.100 |
Why?
|
| Lipids | 1 | 2012 | 235 | 0.100 |
Why?
|
| Models, Anatomic | 1 | 2011 | 22 | 0.100 |
Why?
|
| Observer Variation | 1 | 2011 | 52 | 0.100 |
Why?
|
| Aged | 3 | 2017 | 6741 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 357 | 0.090 |
Why?
|
| Animals | 5 | 2016 | 15081 | 0.090 |
Why?
|
| Surface Properties | 1 | 2011 | 130 | 0.090 |
Why?
|
| Computer Security | 1 | 2010 | 7 | 0.090 |
Why?
|
| Photography | 1 | 2010 | 46 | 0.090 |
Why?
|
| Equipment and Supplies | 1 | 2010 | 10 | 0.090 |
Why?
|
| Telemetry | 1 | 2010 | 14 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 461 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 252 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 27 | 0.090 |
Why?
|
| Young Adult | 2 | 2016 | 4268 | 0.080 |
Why?
|
| Endopeptidases | 1 | 2009 | 59 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 362 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 229 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 2231 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1198 | 0.060 |
Why?
|
| Telomere | 1 | 2023 | 56 | 0.060 |
Why?
|
| Prognosis | 2 | 2016 | 739 | 0.050 |
Why?
|
| Computers | 1 | 2002 | 35 | 0.050 |
Why?
|
| Microscopy | 1 | 2002 | 32 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2002 | 399 | 0.050 |
Why?
|
| Models, Biological | 2 | 2015 | 677 | 0.050 |
Why?
|
| Egg White | 1 | 2020 | 1 | 0.050 |
Why?
|
| Egg Yolk | 1 | 2020 | 3 | 0.050 |
Why?
|
| Surface Tension | 1 | 2020 | 12 | 0.050 |
Why?
|
| Viscosity | 1 | 2020 | 38 | 0.050 |
Why?
|
| Cellulose | 1 | 2020 | 14 | 0.050 |
Why?
|
| Curcumin | 1 | 2020 | 74 | 0.040 |
Why?
|
| Neoplasms | 1 | 2009 | 1103 | 0.040 |
Why?
|
| Pregnancy | 1 | 2002 | 1549 | 0.040 |
Why?
|
| Radiotherapy, Conformal | 1 | 2016 | 2 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 17 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 153 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 208 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 219 | 0.030 |
Why?
|
| Texas | 1 | 2016 | 324 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 562 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 56 | 0.030 |
Why?
|
| Equipment Design | 1 | 2015 | 124 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 198 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 157 | 0.030 |
Why?
|
| Body Height | 1 | 2015 | 53 | 0.030 |
Why?
|
| Mice | 2 | 2016 | 5913 | 0.030 |
Why?
|
| Recurrence | 1 | 2014 | 131 | 0.030 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2013 | 2 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2013 | 13 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 885 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 311 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2013 | 150 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 148 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 626 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2012 | 18 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 1369 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2014 | 326 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 259 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 295 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 502 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2013 | 133 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 1455 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 119 | 0.030 |
Why?
|
| RNA Interference | 1 | 2012 | 243 | 0.020 |
Why?
|
| Umbilicus | 1 | 2010 | 4 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 854 | 0.020 |
Why?
|
| Nipples | 1 | 2010 | 14 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 409 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 864 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 67 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2009 | 41 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 923 | 0.020 |
Why?
|
| Male | 2 | 2016 | 20025 | 0.020 |
Why?
|